GLENMARK - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 2.9
| Stock Code | GLENMARK | Market Cap | 60,822 Cr. | Current Price | 2,154 ₹ | High / Low | 2,474 ₹ |
| Stock P/E | 38.0 | Book Value | 856 ₹ | Dividend Yield | 0.12 % | ROCE | 6.51 % |
| ROE | 6.58 % | Face Value | 1.00 ₹ | DMA 50 | 2,224 ₹ | DMA 200 | 2,066 ₹ |
| Chg in FII Hold | 1.15 % | Chg in DII Hold | -0.81 % | PAT Qtr | 295 Cr. | PAT Prev Qtr | 426 Cr. |
| RSI | 41.4 | MACD | -40.3 | Volume | 3,25,813 | Avg Vol 1Wk | 4,51,838 |
| Low price | 1,612 ₹ | High price | 2,474 ₹ | PEG Ratio | 82.6 | Debt to equity | 0.00 |
| 52w Index | 62.9 % | Qtr Profit Var | 9.79 % | EPS | -7.12 ₹ | Industry PE | 32.1 |
GLENMARK shows weak fundamentals with low ROCE (6.51%) and ROE (6.58%), negative EPS (-₹7.12), and an extremely high PEG ratio (82.6), indicating severe overvaluation. The current price (₹2,154) is below the 50 DMA (₹2,224) but above the 200 DMA (₹2,066), reflecting short-term weakness with medium-term support. RSI at 41.4 and negative MACD (-40.3) confirm bearish momentum. Institutional activity is mixed, with FII holdings increasing (+1.15%) but DII holdings decreasing (-0.81%). Overall, GLENMARK is a risky candidate for swing trading.
🎯 Optimal Entry Price
Entry around ₹2,050–2,100 (near 200 DMA support) is favorable only for high-risk swing traders.
📈 Exit Strategy
If already holding, consider exiting near ₹2,250–2,300 (short-term resistance). A strict stop-loss below ₹2,000 is essential to manage downside risk.
✅ Positive
- 📌 Trading above 200 DMA (₹2,066), showing medium-term support.
- 📌 FII holdings increased (+1.15%), indicating foreign investor confidence.
- 📌 Debt-free balance sheet (Debt-to-equity 0.00).
⚠️ Limitation
- 📌 Weak ROCE (6.51%) and ROE (6.58%).
- 📌 Negative EPS (-₹7.12) reflects poor earnings quality.
- 📌 Extremely high PEG ratio (82.6) indicates severe overvaluation.
- 📌 RSI at 41.4 suggests weak momentum.
- 📌 MACD at -40.3 confirms bearish trend.
- 📌 DII holdings decreased (-0.81%), showing reduced domestic confidence.
📰 Company Negative News
- 📌 No major negative news reported, but weak fundamentals and valuation concerns dominate.
🌟 Company Positive News
- 📌 Foreign institutional inflows (+1.15%) provide some support.
🏭 Industry
- 📌 Industry P/E at 32.1 is lower than GLENMARK’s 38.0, suggesting overvaluation.
- 📌 Pharmaceutical sector outlook remains steady, but valuations are stretched.
🔎 Conclusion
GLENMARK is a weak swing trade candidate due to poor fundamentals and bearish technicals. Entry near ₹2,050–2,100 may be considered cautiously, with exit targets around ₹2,250–2,300. Strict stop-loss management is essential to avoid downside risk.
Would you like me to extend this with a momentum chart analysis or a deeper look at pharma industry trends to strengthen this swing trade view?